Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2008

01-09-2008 | lab. Investigation-human/animal tissue

Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)

Authors: Daizo Yoshida, Ryutaro Nomura, Akira Teramoto

Published in: Journal of Neuro-Oncology | Issue 2/2008

Login to get access

Abstract

Degradation and remodelling of the extracellular matrix has been investigated, with the main focus on the balance between matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases (TIMP). Recent reports disclose the presence of a novel MMP-inhibiting cell membrane-anchored glycoprotein designated ‘reversion-inducing cysteine-rich protein with Kazal motifs’ (RECK). Our main aim in this study was to elucidate the role of RECK in cell invasion of pituitary adenomas and its contribution to signal transduction. The function of RECK in cell invasion was investigated by comparing data obtained from full-length RECK clone transfection and gene silencing with RECK mRNA-targeting siRNA. RECK expression was confirmed using real-time RT-PCR and Western blotting. Levels of matrix metalloproteinases (MMP-2 and -9) and TIMP-1 were measured by zymography and reverse zymography, respectively. Cell invasion was examined with a 3-D invasion assay. The signal cascade was investigated by cDNA microarray analysis. As expected, expression of RECK was elevated upon cDNA transfection, and diminished using siRNA. We observed elevation of MMP-2 and -9 expression and consequent 3-D cell invasion in cells under-expressing RECK. However, TIMP expression was not affected by RECK. Analysis with cDNA microarray revealed that RECK additionally upregulates growth hormone-releasing hormone receptor (GHRHR) and latrophilin 2 at the transcriptional level. Our findings collectively suggest that RECK regulates the cell signalling pathway, playing a critical neuroendocrinological role in the pituitary adenoma cell line.
Literature
1.
go back to reference Kim YY, Chae SY, Kim S, Byun Y, Bae YH (2005) Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. J Biomater Sci Polym Ed 16:1521–1535PubMedCrossRef Kim YY, Chae SY, Kim S, Byun Y, Bae YH (2005) Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. J Biomater Sci Polym Ed 16:1521–1535PubMedCrossRef
2.
go back to reference Tischer T, Vogt S, Aryee S, Steinhauser E, Adamczyk C, Milz S, Martinek V, Imhoff AB (2007) Tissue engineering of the anterior cruciate ligament: a new method using acellularized tendon allografts and autologous fibroblasts. Arch Orthop Trauma Surg 127:735–741PubMedCrossRef Tischer T, Vogt S, Aryee S, Steinhauser E, Adamczyk C, Milz S, Martinek V, Imhoff AB (2007) Tissue engineering of the anterior cruciate ligament: a new method using acellularized tendon allografts and autologous fibroblasts. Arch Orthop Trauma Surg 127:735–741PubMedCrossRef
3.
go back to reference Tunuguntla R, Ripley D, Sang QX, Chegini N (2003) Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89:453–459PubMedCrossRef Tunuguntla R, Ripley D, Sang QX, Chegini N (2003) Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89:453–459PubMedCrossRef
4.
go back to reference Bendardaf R, Buhmeida A, Ristamaki R, Syrjanen K, Pyrhonen S (2007) MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol 1–6 (Epub ahead of print) Bendardaf R, Buhmeida A, Ristamaki R, Syrjanen K, Pyrhonen S (2007) MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol 1–6 (Epub ahead of print)
5.
go back to reference Bister V, Skoog T, Virolainen S, Kiviluoto T, Puolakkainen P, Saarialho-Kere U (2007) Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma. Mod Pathol 20:1128–1140PubMedCrossRef Bister V, Skoog T, Virolainen S, Kiviluoto T, Puolakkainen P, Saarialho-Kere U (2007) Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma. Mod Pathol 20:1128–1140PubMedCrossRef
6.
go back to reference Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, Jonguitud-Olguin G, Rodriguez-Hernandez A, Anaya-Ventura A, Baltazar-Rodriguez LM, Orozco-Ruiz M, Soriano-Hernandez AD, Rodriguez-Sanchez IP, Lugo-Trampe A, Espinoza-Gomez F, Michel-Peregrina ML (2007) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 65:68–72PubMedCrossRef Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, Jonguitud-Olguin G, Rodriguez-Hernandez A, Anaya-Ventura A, Baltazar-Rodriguez LM, Orozco-Ruiz M, Soriano-Hernandez AD, Rodriguez-Sanchez IP, Lugo-Trampe A, Espinoza-Gomez F, Michel-Peregrina ML (2007) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 65:68–72PubMedCrossRef
7.
go back to reference Takagi S, Kato Y, Asano K, Ohsaki T, Bosnakovski D, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T (2005) Matrix metalloproteinase inhibitor RECK expression in canine tumors. J Veter Med Sci/Jpn Soc Veter Sci 67:761–767 Takagi S, Kato Y, Asano K, Ohsaki T, Bosnakovski D, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T (2005) Matrix metalloproteinase inhibitor RECK expression in canine tumors. J Veter Med Sci/Jpn Soc Veter Sci 67:761–767
8.
go back to reference Accorsi-Mendonca T, Paiva KB, Zambuzzi WF, Cestari TM, Lara VS, Sogayar MC, Taga R, Granjeiro JM (2007) Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat. J Mol Histol 39(2):201–208PubMedCrossRef Accorsi-Mendonca T, Paiva KB, Zambuzzi WF, Cestari TM, Lara VS, Sogayar MC, Taga R, Granjeiro JM (2007) Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat. J Mol Histol 39(2):201–208PubMedCrossRef
9.
go back to reference Clark JC, Thomas DM, Choong PF, Dass CR (2007) RECK-a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26:675–683PubMedCrossRef Clark JC, Thomas DM, Choong PF, Dass CR (2007) RECK-a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26:675–683PubMedCrossRef
10.
go back to reference Kawashima S, Imamura Y, Chandana EP, Noda T, Takahashi R, Adachi E, Takahashi C, Noda M (2007) Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions. J Neurochem 104(2):376–385PubMed Kawashima S, Imamura Y, Chandana EP, Noda T, Takahashi R, Adachi E, Takahashi C, Noda M (2007) Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions. J Neurochem 104(2):376–385PubMed
11.
go back to reference Takagi S, Hoshino Y, Osaki T, Okumura M, Fuginaga T (2007) Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines. Exp Oncol 29:30–34PubMed Takagi S, Hoshino Y, Osaki T, Okumura M, Fuginaga T (2007) Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines. Exp Oncol 29:30–34PubMed
12.
go back to reference Ong EK, Suphioglu C, Singh MB, Knox RB (1990) Immunodetection methods for grass pollen allergens on western blots. Int Arch Allergy Appl Immunol 93:338–343PubMed Ong EK, Suphioglu C, Singh MB, Knox RB (1990) Immunodetection methods for grass pollen allergens on western blots. Int Arch Allergy Appl Immunol 93:338–343PubMed
13.
go back to reference Le QT, Ohashi A, Hirose S, Katunuma N (2005) Reverse zymography using fluorogenic substrates for protease inhibitor detection. Electrophoresis 26:1038–1045PubMedCrossRef Le QT, Ohashi A, Hirose S, Katunuma N (2005) Reverse zymography using fluorogenic substrates for protease inhibitor detection. Electrophoresis 26:1038–1045PubMedCrossRef
14.
go back to reference Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS (2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90:81–88PubMedCrossRef Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS (2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90:81–88PubMedCrossRef
15.
go back to reference Yoshida D, Teramoto A (2007) The use of 3-D culture in peptide hydoegel for analysis of discoidin domain receptor 1-collagen interaction. Cell Adhesion Migrat 1:92–98 Yoshida D, Teramoto A (2007) The use of 3-D culture in peptide hydoegel for analysis of discoidin domain receptor 1-collagen interaction. Cell Adhesion Migrat 1:92–98
16.
go back to reference Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G (2004) Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci 25:251–256PubMedCrossRef Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G (2004) Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci 25:251–256PubMedCrossRef
17.
go back to reference Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S, Wass JA (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol (Oxf) 67:938–943 CrossRef Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S, Wass JA (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol (Oxf) 67:938–943 CrossRef
18.
go back to reference Chang CZ, Huang YH, Howng SL (2000) Follow-up of invasive pituitary macroadenoma in 56 patients within a duration of 5 years. Kaohsiung J Med Sci 16:339–344PubMed Chang CZ, Huang YH, Howng SL (2000) Follow-up of invasive pituitary macroadenoma in 56 patients within a duration of 5 years. Kaohsiung J Med Sci 16:339–344PubMed
19.
go back to reference Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MB, Hussaini IM, Laws ER (2008) Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11:37–48PubMedCrossRef Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MB, Hussaini IM, Laws ER (2008) Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11:37–48PubMedCrossRef
20.
go back to reference Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws ER Jr (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356–365PubMedCrossRef Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws ER Jr (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356–365PubMedCrossRef
21.
go back to reference Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Ludecke DK, Saeger W (2003) Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol 106:471–478PubMedCrossRef Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Ludecke DK, Saeger W (2003) Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol 106:471–478PubMedCrossRef
22.
go back to reference Liu W, Kunishio K, Matsumoto Y, Okada M, Nagao S (2005) Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. J Clin Neurosci 12:791–794PubMedCrossRef Liu W, Kunishio K, Matsumoto Y, Okada M, Nagao S (2005) Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. J Clin Neurosci 12:791–794PubMedCrossRef
23.
go back to reference Liu W, Matsumoto Y, Okada M, Miyake K, Kunishio K, Kawai N, Tamiya T, Nagao S (2005) Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J Med Invest 52:151–158PubMedCrossRef Liu W, Matsumoto Y, Okada M, Miyake K, Kunishio K, Kawai N, Tamiya T, Nagao S (2005) Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J Med Invest 52:151–158PubMedCrossRef
24.
go back to reference Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JA (2000) Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metabol 85:2931–2935CrossRef Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JA (2000) Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metabol 85:2931–2935CrossRef
25.
go back to reference Yoshida D, Teramoto A (2007) Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. J Neuro-oncol 82:29–40CrossRef Yoshida D, Teramoto A (2007) Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. J Neuro-oncol 82:29–40CrossRef
26.
go back to reference Takagi S, Kitamura T, Hosaka Y, Ohsaki T, Bosnakovski D, Kadosawa T, Okumura M, Fujinaga T (2005) Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK. J Veter Med Sci/Jpn Soc Veter Sci 67:385–391 Takagi S, Kitamura T, Hosaka Y, Ohsaki T, Bosnakovski D, Kadosawa T, Okumura M, Fujinaga T (2005) Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK. J Veter Med Sci/Jpn Soc Veter Sci 67:385–391
27.
go back to reference Welm B, Mott J, Werb Z (2002) Developmental biology: vasculogenesis is a wreck without RECK. Curr Biol 12:R209–211PubMedCrossRef Welm B, Mott J, Werb Z (2002) Developmental biology: vasculogenesis is a wreck without RECK. Curr Biol 12:R209–211PubMedCrossRef
28.
go back to reference Chang HC, Cho CY, Hung WC (2007) Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci 98:169–173PubMedCrossRef Chang HC, Cho CY, Hung WC (2007) Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci 98:169–173PubMedCrossRef
29.
go back to reference Cho CY, Wang JH, Chang HC, Chang CK, Hung WC (2007) Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol 213:65–69PubMedCrossRef Cho CY, Wang JH, Chang HC, Chang CK, Hung WC (2007) Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. J Cell Physiol 213:65–69PubMedCrossRef
30.
go back to reference Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK (2007) Matrix metalloproteinase-9 activity is associated with poor prognosis in T3–T4 node-negative colorectal cancer. Hum Pathol 38:1603–1610PubMedCrossRef Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK (2007) Matrix metalloproteinase-9 activity is associated with poor prognosis in T3–T4 node-negative colorectal cancer. Hum Pathol 38:1603–1610PubMedCrossRef
31.
go back to reference Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I (2007) RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J Orthop Res 25:696–702PubMedCrossRef Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I (2007) RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J Orthop Res 25:696–702PubMedCrossRef
32.
go back to reference Ohta S, Lai EW, Morris JC, Pang AL, Watanabe M, Yazawa H, Zhang R, Green JE, Chan WY, Sirajuddin P, Taniguchi S, Powers JF, Tischler AS, Pacak K (2007) Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Mol Carcinog 47:245–251 Ohta S, Lai EW, Morris JC, Pang AL, Watanabe M, Yazawa H, Zhang R, Green JE, Chan WY, Sirajuddin P, Taniguchi S, Powers JF, Tischler AS, Pacak K (2007) Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Mol Carcinog 47:245–251
33.
go back to reference Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada JI, Miyamoto M, Kondo S, Moriuchi T (2007) Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer 58:376–383PubMedCrossRef Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada JI, Miyamoto M, Kondo S, Moriuchi T (2007) Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer 58:376–383PubMedCrossRef
34.
go back to reference Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS (2006) Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness. J Cell Biochem 99:156–167PubMedCrossRef Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS (2006) Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness. J Cell Biochem 99:156–167PubMedCrossRef
35.
go back to reference Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22:167–175PubMedCrossRef Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22:167–175PubMedCrossRef
36.
go back to reference Doyle SE, Scholz MJ, Greer KA, Hubbard AD, Darnell DK, Antin PB, Klewer SE, Runyan RB (2006) Latrophilin-2 is a novel component of the epithelial–mesenchymal transition within the atrioventricular canal of the embryonic chicken heart. Dev Dyn 235:3213–3221PubMedCrossRef Doyle SE, Scholz MJ, Greer KA, Hubbard AD, Darnell DK, Antin PB, Klewer SE, Runyan RB (2006) Latrophilin-2 is a novel component of the epithelial–mesenchymal transition within the atrioventricular canal of the embryonic chicken heart. Dev Dyn 235:3213–3221PubMedCrossRef
37.
go back to reference Osada S, Ikeda T, Xu M, Nishihara T, Imagawa M (1997) Identification of the transcriptional repression domain of nuclear factor 1-A. Biochem Biophys Res Commun 238:744–747PubMedCrossRef Osada S, Ikeda T, Xu M, Nishihara T, Imagawa M (1997) Identification of the transcriptional repression domain of nuclear factor 1-A. Biochem Biophys Res Commun 238:744–747PubMedCrossRef
38.
go back to reference Barnes SL, Vidrich A, Wang ML, Wu GD, Cominelli F, Rivera-Nieves J, Bamias G, Cohn SM (2007) Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J Immunol 179:7012–7020PubMed Barnes SL, Vidrich A, Wang ML, Wu GD, Cominelli F, Rivera-Nieves J, Bamias G, Cohn SM (2007) Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J Immunol 179:7012–7020PubMed
39.
go back to reference Fainstein Day P, Frohman L, Garcia Rivello H, Reubi JC, Sevlever G, Glerean M, Fernandez Gianotti T, Pietrani M, Rabadan A, Racioppi S, Bidlingmaier M (2007) Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary 10:311–319PubMedCrossRef Fainstein Day P, Frohman L, Garcia Rivello H, Reubi JC, Sevlever G, Glerean M, Fernandez Gianotti T, Pietrani M, Rabadan A, Racioppi S, Bidlingmaier M (2007) Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary 10:311–319PubMedCrossRef
41.
go back to reference Roh SG, Doconto M, Feng DD, Chen C (2006) Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH. Endocrine 30:55–62PubMedCrossRef Roh SG, Doconto M, Feng DD, Chen C (2006) Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH. Endocrine 30:55–62PubMedCrossRef
42.
go back to reference Annabi B, Bouzeghrane M, Currie JC, Hawkins R, Dulude H, Daigneault L, Ruiz M, Wisniewski J, Garde S, Rabbani SA, Panchal C, Wu JJ, Beliveau R (2005) A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. Clin Exp Metastasis 22:429–439PubMedCrossRef Annabi B, Bouzeghrane M, Currie JC, Hawkins R, Dulude H, Daigneault L, Ruiz M, Wisniewski J, Garde S, Rabbani SA, Panchal C, Wu JJ, Beliveau R (2005) A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. Clin Exp Metastasis 22:429–439PubMedCrossRef
Metadata
Title
Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)
Authors
Daizo Yoshida
Ryutaro Nomura
Akira Teramoto
Publication date
01-09-2008
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2008
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9606-5

Other articles of this Issue 2/2008

Journal of Neuro-Oncology 2/2008 Go to the issue